Status:
UNKNOWN
3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors
Lead Sponsor:
Blokhin's Russian Cancer Research Center
Conditions:
Tumor of Bone
Chest Wall Tumor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A patient with a tumor lesion of the chest wall undergoes CT scan with a step width of less than 1 mm, then engineers design an individual model to replace the defect. Using a 3D printer, a model is m...
Detailed Description
A patient with a tumor lesion of the chest wall undergoes CT scan with a step width of less than 1 mm, then engineers design an individual model to replace the defect. Using a 3D printer, a model is m...
Eligibility Criteria
Inclusion Criteria:
- Malignant neoplasm of ribs, sternum and clavicle
- Malignant neoplasm of the connective and soft tissues of the chest
- Neoplasm of uncertain or unknown nature of ribs, sternum and collarbone
- Benign neoplasm of ribs, sternum and collarbone
- Tumor lesions of the chest wall of any localization, malignant and benign, as well as of an uncertain or unknown nature
- For malignant tumors: Grade 1-3
- Lack of distant metastases
- Signed informed consent
Exclusion Criteria:
- Children, women during pregnancy, childbirth, women during breastfeeding.
- Military personnel, with the exception of contract military personnel.
- Persons with mental disorders.
- Persons detained, taken into custody, serving a sentence in the form of restriction of freedom, arrest, imprisonment or administrative arrest.
- Patients with distant metastases (except for a solitary focus in the chest wall without other manifestations of the disease)
- Inoperable tumor
- The presence of another malignant tumor at the time of examination
- ECOG 4
- Having an active or chronic fungal / bacterial / viral infection
- Uncontrolled chronic diseases of the liver, kidneys in the acute stage
- Presence of metastases
Key Trial Info
Start Date :
January 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05057143
Start Date
January 10 2022
End Date
December 1 2025
Last Update
April 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal State Budgetary Institution "N.N. Blokhin National Medical Research Center of Oncology" оf the Ministry of Health of the Russian Federation
Moscow, Russia, 115478